Feltner D, Hill C, Lenderking W, Williams VS, Morlock R. Development of a patient-reported assessment to identify placebo responders in a generalized anxiety disorder trial. J Psychiatr Res. 2009 Oct;43(15):1224-30.
Morlock RJ, Williams VS, Cappelleri JC, Harness J, Fehnel SE, Endicott J, Feltner D. Development and evaluation of the Daily Assessment of Symptoms – Anxiety (DAS-A) Scale to evaluate onset of symptom relief in patients with generalized anxiety disorder. J Psychiatr Res. 2008 Oct;42(12):1024-36.
Scotland GS, Philip S, Fleming AD, Goatman KA, Sharp PF, McNamee P, Fonseca S, Prescott G, Olson JA. Manual versus automated: the diabetic retinopathy screening debate. OTE. 2008 Jan 1;4(2):14-6.
Clarkson TB, Anthony MS. Effects of SERMs, tibolone, and soy isoflavones on cardiovascular risk factors and coronary artery atherosclerosis of surgically post-menopausal monkeys. J Menopausal Med. 2001;10(1):19-23.